PhilosophyTeamPORtfolioInvestors
NewsBlogFAQsLet's Talk
PhilosophyTeamPortfolioInvestorsNewsBlogFAQsLet's Talk
Back To All Companies

ODAIA

CareersTwitterLinkedInCompany Website
ODAIA combines multivariate data analytics, process mining and AI to deliver a Customer Data Platform (CDP) for predictive analytics and insights to pharmaceutical commercial teams. ODAIA’s SaaS CDP, MAPTUAL, offers predictive targeting and sales forecasting, physician segmentation, omni-channel attribution and next-best-engagement, bringing predictive analytics and efficiencies to pharma commercial teams.
Founders

Helen Kontozopoulos
Philip Poulidis

Sector
Enterprise SaaS
Location
Toronto, ON
Status
Active
Exited

ODAIA News

PR Newswire
November 19, 2025
ODAIA Adds Senior Pharma and AI Leaders to Accelerate Growth and Industry Adoption
PR Newswire
October 22, 2025
ODAIA Introduces Brand Strategy Studio to Bridge the Gap Between Pharma Brand Planning and Commercial Execution
ODAIA Blog / Press
May 7, 2024
ODAIA Partners with Veeva to Accelerate Adoption of AI in Life Sciences
Betakit
May 1, 2023
Odaia Closes $34Million CAD Series B to Fix "Bottleneck" In Drug Delivery Process
TechCrunch
February 10, 2022
ODAIA raises $13.8M for its AI-powered commercial insights platform for pharma companies
BetaKit
February 10, 2022
ODAIA secures $17.5 million CAD to help pharma firms focus their sales and marketing with AI
Pharmaceutical Technology
June 17, 2021
ODAIA: Changing the face of pharma sales with AI
BetaKit
May 18, 2021
With its platform now on the market, ODAIA bets on pharma